A Systematic Review of Cognitive Predictors of Treatment Outcome in Major Depression
- PMID: 30210368
- PMCID: PMC6121150
- DOI: 10.3389/fpsyt.2018.00382
A Systematic Review of Cognitive Predictors of Treatment Outcome in Major Depression
Abstract
Background: Research suggests that only 50% of patients with major depression respond to psychotherapy or pharmacological treatment, and relapse is common. Therefore, there is interest in elucidating factors that help predict clinical response. Cognitive impairment is a key feature of depression, which often persists beyond remission; thus, the aim of this systematic review was to determine whether baseline cognitive functioning can predict treatment outcomes in individuals with depression. Method: Studies examining cognitive predictors of treatment response in depression were identified using Pub Med and Web of Science databases. Given the heterogeneity of outcome measures, the variety of treatment protocols, and the differing ways in which data was presented and analyzed, a narrative rather than meta-analytic review technique was used. Results: 39 studies met inclusion criteria. Findings in younger adult samples were inconclusive. There was some evidence for a predictive effect of executive function and to a lesser extent, psychomotor speed, on treatment response. There was no evidence of learning or memory being associated with treatment response. In older-aged samples, the evidence was much more consistent, suggesting that poor executive function predicts poor response to SSRIs. Conclusions: Findings from the present review suggest that certain aspects of cognitive functioning, particularly executive function, may be useful in predicting treatment response in depression. This is certainly the case in elderly samples, with evidence suggesting that poor executive functioning predicts poor response to SSRIs. With further research, baseline cognitive functioning may serve as a factor which helps guide clinical decision making. Moreover, cognitive deficits may become targets for specific pharmacological or psychological treatments, with the hope of improving overall outcome.
Keywords: cognitive function; cognitive predictors; executive function; major depression; relapse; remission; treatment response.
Figures
Similar articles
-
Cognitive deficits in bipolar disorders: Implications for emotion.Clin Psychol Rev. 2018 Feb;59:126-136. doi: 10.1016/j.cpr.2017.11.006. Epub 2017 Nov 21. Clin Psychol Rev. 2018. PMID: 29195773 Free PMC article. Review.
-
Baseline predictors of cognitive change in the treatment of major depressive episode: systematic review.BJPsych Open. 2020 Oct 30;6(6):e131. doi: 10.1192/bjo.2020.114. BJPsych Open. 2020. PMID: 33121560 Free PMC article.
-
Does cognition predict treatment response and remission in psychotherapy for late-life depression?Am J Geriatr Psychiatry. 2015 Feb;23(2):215-9. doi: 10.1016/j.jagp.2014.09.003. Epub 2014 Sep 21. Am J Geriatr Psychiatry. 2015. PMID: 25441055 Free PMC article. Clinical Trial.
-
Cognitive function following a major depressive episode: a systematic review and meta-analysis.Lancet Psychiatry. 2019 Oct;6(10):851-861. doi: 10.1016/S2215-0366(19)30291-3. Epub 2019 Aug 15. Lancet Psychiatry. 2019. PMID: 31422920
-
A Meta-Analysis of Executive Dysfunction and Antidepressant Treatment Response in Late-Life Depression.Am J Geriatr Psychiatry. 2016 Jan;24(1):31-41. doi: 10.1016/j.jagp.2015.05.010. Epub 2015 May 21. Am J Geriatr Psychiatry. 2016. PMID: 26282222 Free PMC article. Review.
Cited by
-
Neuroimaging features of cognitive impairments in schizophrenia and major depressive disorder.Ther Adv Psychopharmacol. 2024 May 4;14:20451253241243290. doi: 10.1177/20451253241243290. eCollection 2024. Ther Adv Psychopharmacol. 2024. PMID: 38708374 Free PMC article. Review.
-
Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: A systematic review by the International Society for Bipolar Disorders Targeting Cognition Task Force.Bipolar Disord. 2022 Jun;24(4):354-374. doi: 10.1111/bdi.13193. Epub 2022 Feb 24. Bipolar Disord. 2022. PMID: 35174594 Free PMC article.
-
μ Opioid Antagonist Naltrexone Partially Abolishes the Antidepressant Placebo Effect and Reduces Orbitofrontal Cortex Encoding of Reinforcement.Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Oct;6(10):1002-1012. doi: 10.1016/j.bpsc.2021.02.009. Epub 2021 Mar 6. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021. PMID: 33684624 Free PMC article. Clinical Trial.
-
Decreased functional connectivity of the insula within the salience network as an indicator for prospective insufficient response to antidepressants.Neuroimage Clin. 2019;24:102064. doi: 10.1016/j.nicl.2019.102064. Epub 2019 Nov 6. Neuroimage Clin. 2019. PMID: 31795046 Free PMC article.
-
Dealing with heterogeneity of cognitive dysfunction in acute depression: a clustering approach.Psychol Med. 2021 Dec;51(16):2886-2894. doi: 10.1017/S0033291720001567. Epub 2020 Jun 1. Psychol Med. 2021. PMID: 32476636 Free PMC article.
References
-
- GBD 2016 Disease and injury incidence and prevalence collaborators global regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet (2017) 390:1211–59. 10.1016/S0140-6736(17)32154-2 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous